Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
Clinical trial NCT03514017 · TERMINATED
Trial details
- NCT number
- NCT03514017
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-31
- Primary completion
- 2023-05-16
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.